Pingyangmycin
http://dbpedia.org/resource/Pingyangmycin an entity of type: Thing
Pingyangmycin (Bleomycin A5) ist ein Antibiotikum aus Streptomyces verticillus var. pingyangensis n.sp., benannt nach Pingyang (Kreis in der chinesischen Provinz Zhejiang). Streptomyceten bilden eine Gattung der Actinobacteria. Pingyangmycin ist ein Einzelverbindung aus der Stoffgruppe der Bleomycine und stellt das Spermidin-Amid der Bleomycinsäure dar. Pingyangmycin findet Verwendung als Zytostatikum in der Chemotherapie.
rdf:langString
Pingyangmycin (also known as bleomycin A5) is an antitumor glycopeptide antibiotic belonging to the bleomycin family, which is produced by Streptomyces verticillus var. pingyangensis n.sp., a variety of Streptomyces verticillus. It was discovered in 1969 at Pingyang County of Zhejiang Province in China, and was brought into clinical use in 1978.
rdf:langString
rdf:langString
Pingyangmycin
rdf:langString
Pingyangmycin
xsd:integer
35744573
xsd:integer
1083643301
xsd:integer
57
xsd:integer
11116
xsd:integer
8232875
<second>
4680.0
xsd:integer
89
xsd:integer
-2
rdf:langString
Rx-only
xsd:double
1440.56126
xsd:integer
19
xsd:integer
21
rdf:langString
D
xsd:integer
84046
rdf:langString
intravenous, intra-arterial, intramuscular, intratumoral
xsd:integer
2
rdf:langString
C[C@@H][C@H]CNCCc1nc-c1ncCNCCCNCCCCN
xsd:integer
1
rdf:langString
QYOAUOAXCQAEMW-UTXKDXHTSA-N
rdf:langString
Bleomycin A5
xsd:integer
5
xsd:integer
300
rdf:langString
Pingyangmycin (Bleomycin A5) ist ein Antibiotikum aus Streptomyces verticillus var. pingyangensis n.sp., benannt nach Pingyang (Kreis in der chinesischen Provinz Zhejiang). Streptomyceten bilden eine Gattung der Actinobacteria. Pingyangmycin ist ein Einzelverbindung aus der Stoffgruppe der Bleomycine und stellt das Spermidin-Amid der Bleomycinsäure dar. Pingyangmycin findet Verwendung als Zytostatikum in der Chemotherapie.
rdf:langString
Pingyangmycin (also known as bleomycin A5) is an antitumor glycopeptide antibiotic belonging to the bleomycin family, which is produced by Streptomyces verticillus var. pingyangensis n.sp., a variety of Streptomyces verticillus. It was discovered in 1969 at Pingyang County of Zhejiang Province in China, and was brought into clinical use in 1978. In China, pingyangmycin has largely superseded bleomycin A2 (commonly known as "bleomycin"), since according to Chinese sources it is more effective, costs less, is easier to get, can treat a larger variety of cancers (such as breast cancer and liver cancer) and causes less lung injury. Though pingyangmycin and bleomycin can each cause pulmonary fibrosis, pingyangmycin's most serious side effect - which it does not share with bleomycin - is anaphylactic shock, which is rare, but may happen even in a low dose, and can be fatal. In addition, it causes a higher incidence of fever than bleomycin; the occurrence of this complication in patients is between 20 and 50%.
xsd:nonNegativeInteger
5165
xsd:string
11116-32-8
xsd:string
5DY91Y7601
xsd:string
84046